Belouchi N E, Roux E, Savineau J P, Marthan R
Laboratoire de physiologie cellulaire respiratoire, INSERM E9937, université Victor Segalen Bordeaux 2, France.
Fundam Clin Pharmacol. 2000 Jul-Aug;14(4):395-400. doi: 10.1111/j.1472-8206.2000.tb00421.x.
It has been shown in vitro that general anaesthetics modify airway responsiveness via, at least partially, a direct inhibitory effect on calcium signalling in airway smooth muscle cells. However, in vivo, these anaesthetic compounds bind serum proteins. We have investigated the effect of exposure to extracellular albumin of freshly isolated airway smooth muscle cells on the propofol- and etomidate-induced inhibitory effect on calcium signalling. [Ca2+]i was measured by microspectrofluorimetry in rat isolated tracheal smooth muscle cells using the fluorescent dye indo-1. Propofol (3 x 10(-4) M) and etomidate (10(-4) M) were the lowest 'effective' concentrations that altered the [Ca2+]i response. This alteration consisted of a decrease in both the amplitude of the [Ca2+]i peak (from 358 +/- 13 nM to 65 +/- 15 and 108 +/- 27 nM for propofol and etomidate, respectively) and the percentage of responding cells (from 80% to 37 and 25% respectively) in response to the low concentration of ACh and a decrease in the Ca2+ oscillation frequency (from 9.9 +/- 0.3 min(-1) to 4.7 +/- 0.4 and 6.9 +/- 0.4 min(-1), respectively) in response to the high concentration of ACh. Increasing the concentration of albumin reduced the inhibitory effect of etomidate and propofol on the [Ca2+]i response to ACh. When extracellular albumin concentration was kept constant (20 g/L), increasing the concentration of etomidate by one log restored its inhibitory effect on the calcium signal. This study indicates that increasing the concentration of extracellular albumin reduces the inhibitory effect of intravenous anaesthetics on calcium signalling in airway smooth muscle cells. This report suggests that, in extrapolating in vitro dose-response relationships to those from in vivo conditions, the effect of the concentration of extracellular protein can be estimated.
体外实验表明,全身麻醉药至少部分通过对气道平滑肌细胞钙信号的直接抑制作用来改变气道反应性。然而,在体内,这些麻醉化合物会与血清蛋白结合。我们研究了新鲜分离的气道平滑肌细胞暴露于细胞外白蛋白对丙泊酚和依托咪酯诱导的钙信号抑制作用的影响。使用荧光染料indo-1,通过显微分光荧光测定法在大鼠离体气管平滑肌细胞中测量[Ca2+]i。丙泊酚(3×10(-4)M)和依托咪酯(10(-4)M)是改变[Ca2+]i反应的最低“有效”浓度。这种改变包括[Ca2+]i峰值幅度降低(丙泊酚和依托咪酯分别从358±13 nM降至65±15 nM和108±27 nM)以及对低浓度乙酰胆碱反应的反应细胞百分比降低(分别从80%降至37%和25%),以及对高浓度乙酰胆碱反应的Ca2+振荡频率降低(分别从9.9±0.3 min(-1)降至4.7±0.4 min(-1)和6.9±0.4 min(-1))。增加白蛋白浓度可降低依托咪酯和丙泊酚对乙酰胆碱[Ca2+]i反应的抑制作用。当细胞外白蛋白浓度保持恒定(20 g/L)时,将依托咪酯浓度增加一个对数可恢复其对钙信号的抑制作用。本研究表明,增加细胞外白蛋白浓度可降低静脉麻醉药对气道平滑肌细胞钙信号的抑制作用。本报告表明,在将体外剂量反应关系外推至体内条件时,可以估计细胞外蛋白质浓度的影响。